Cloud Banner

Healthcare

Image

Global Virology Testing Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Virology Testing Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - 8.200000000000001% Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 4108.27 Million
Diagram Market Size (Forecast Year) USD 7717.51 Million
Diagram CAGR 8.200000000000001%

Global Virology Testing Market, By Procedure (Cell Culture Method, Specific Antibodies Detection, Antigen Detection, Virus Nucleic Acid Detection, Gene Sequencing, Hemagglutination Assays), Diagnosis Test (Hepatitis B, Hepatitis C, HIV, Human Papillomavirus (HPV), Other Tests), Method (Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy, Interferon's (Cytokines)), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections), End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies) – Industry Trends and Forecast to 2029.

Virology Testing Market Analysis and Size

The virology testing market is expected to grow at a significant growth rate. The new advanced molecular-based virology testing methods, such as immunoassay, mass spectrometry-based detection methods, nucleic acid-based amplification testing methods, and next-generation genome sequencing methods, are precise, quick, and provides the result for various viral infections.

Data Bridge Market Research analyses that the virology testing market which was USD 4,108.27 million in 2021, would rocket up to USD 7717.51 million by 2029, and is expected to undergo a CAGR of 8.20% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Virology Testing Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Procedure (Cell Culture Method, Specific Antibodies Detection, Antigen Detection, Virus Nucleic Acid Detection, Gene Sequencing, Hemagglutination Assays), Diagnosis Test (Hepatitis B, Hepatitis C, HIV, Human Papillomavirus (HPV), Other Tests), Method (Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy, Interferon's (Cytokines)), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections), End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Germany), Lonza (Switzerland), Sigma-Aldrich Co. (U.S.), Wuxi AppTec (China), Merck & Co. Inc. (U.S.), Eurofins Scientific (Luxembourg), General Electric (U.S.), Danaher (U.S.), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), BD (U.S.), Biospherix, Ltd (U.S.) and Novogene Co Ltd. (China)

Market Opportunities

  •  Surge in the prevalence of viral diseases worldwide
  •  Increasing product approvals

Market Definition

Testing for viruses includes diagnostic techniques that aid in the early detection of illnesses such as hepatitis, influenza, HIV, sexually transmitted diseases, RCV, and other viruses-related diseases. Virology testing looks for the presence of viral antigens, nucleic acids, and antibodies in the provided sample. There have been identified more than 100 viral illnesses.

Virology Testing Market Dynamics

Drivers

  • Rising number of patients with STDs

In the forecast period of 2022–2029, factors such as the rising number of patients with STDs, STD-related illnesses, and other viruses, as well as the availability of immune suppressive drugs and the rising number of technological advancements in the healthcare industry, are likely to boost the growth of the virology testing market. However, the development of molecular diagnostic technologies will create a number of new chances for the virology testing market to expand during the forecast period.

  • Rising incidence of viral infections

The main driving factors will be the rising incidence of viral infections, the appearance of novel pathogens, and an increase in the number of product approvals. For instance, the World Health Organization (WHO) estimates that in 2021, infectious diseases affected 60% of the world's population. The demand for virology testing has increased due to the rising prevalence of viral illnesses such as human immunodeficiency virus (HIV), influenza, Ebola, Zika virus, and other sexually transmitted diseases.

Opportunities

  • Increased healthcare spending

The rapid adoption of cutting-edge diagnostic and testing techniques, increased healthcare spending, the existence of supportive government policies, and the presence of cutting-edge clinical laboratories and manufacturing businesses have all contributed to the region's market's robust growth over the years. An important reason for the market's expansion is the rise in R&D efforts from public and commercial organizations in the United States.

Restraints/Challenges

  • Stringent regulations regarding product development and approvals

On the other hand, the stringent approval processes along with side effects of drugs and other treatment options will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the virology testing market.

This virology testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the virology testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Virology Testing Market

The COVID-19 pandemic has also significantly impacted the development of the segment. Nearly all diagnostic tests employ RT-PCR to screen the population who have COVID-19 symptoms because the authorities have not recommended the specific viral culture tests. To find novel compounds or leads for the treatment of COVID-19, the majority of pharmaceutical and biotechnological businesses are concentrating on research and development operations.

Recent Development

  • In May 2021, In collaboration with Ubio Biotechnology Systems Pvt. Ltd., Cipla Limited introduced "ViraGen" as a polymerase chain reaction (COVID-19 RT-PCR) test for COVID-19 in India.
  • In May 2022, QuantuMDx Group Limited announced the release of Q-POC SARS-CoV-2, Flu A/B & RSV Assay, a novel respiratory panel test. Rapid point-of-care testing is offered to customers through the Q-POC platform and its multiplex capabilities in clinical and non-clinical contexts.
  • In January 2022, A brand-new, extremely sensitive SARS-CoV-2 Rapid Antigen Test -AQ+ Covid-19 Ag Rapid Test for usage by professionals was introduced by InTec. The AQ+ Covid-19 Ag Rapid Test is designed to be used by laypeople or medical professionals to quickly and easily detect Covid-19.

Global Virology Testing Market Scope

The virology testing market is segmented on the basis of procedure, diagnosis test, method, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Procedure

  • Cell Culture Method
  • Specific Antibodies Detection
  • Antigen Detection
  • Virus Nucleic Acid Detection
  • Gene Sequencing
  • Hemagglutination Assays

Diagnosis Test

  • Hepatitis B
  • Hepatitis C
  • HIV
  • Human Papillomavirus (HPV)
  • Other Tests

Method

  • Immunoprophylaxis
  • Active Prophylaxis (Vaccines)
  • Passive Prophylaxis
  • Antiviral Chemotherapy
  • Interferon's (Cytokines)

 Application

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Urinary Tract Infection
  • Eye Infections
  • Sexually Transmitted Diseases
  • Perinatal Infections

 End User

  • Hospitals
  • Clinics
  • Laboratories
  • Diagnostic Centers
  • Blood Banks
  • Pharmacies

Virology Testing Market Regional Analysis/Insights

The virology testing market is analysed and market size insights and trends are provided by country, procedure, diagnosis test, method, application and end user as referenced above.

The countries covered in the virology testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the virology testing market due to the technological advancement in portable diagnostics.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to advanced infrastructure development.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The virology testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for virology testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the virology testing market. The data is available for historic period 2010-2020.

Competitive Landscape and Virology Testing Market Share Analysis

The virology testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to virology testing market.

Some of the major players operating in the virology testing market are:

  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Agilent Technologies, Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • QIAGEN (Germany)
  • Lonza (Switzerland)
  • Sigma-Aldrich Co. (U.S.)
  • Wuxi AppTec (China)
  • Merck & Co. Inc. (U.S.)
  • Eurofins Scientific (Luxembourg)
  • General Electric (U.S.)
  • Danaher (U.S.)
  • Sartorius AG (Germany)
  • Bio-Rad Laboratories, Inc. (U.S.)
  •  BD (U.S.)
  • Biospherix, Ltd (U.S.)
  • Novogene Co Ltd. (China)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The virology testing market value is expected USD 7717.51 million by 2029.
The virology testing market is projected to grow at a CAGR of 8.20% during the forecast period of 2022-2029.
The major players operating in the Virology Testing Market are F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Germany), Lonza (Switzerland), Sigma-Aldrich Co. (U.S.), Wuxi AppTec (China), Merck & Co. Inc. (U.S.), Eurofins Scientific (Luxembourg), General Electric (U.S.), Danaher (U.S.), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), BD (U.S.), Biospherix, Ltd (U.S.) and Novogene Co Ltd. (China).
On the basis of application, the Virology Testing Market is segmented into Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials